Logo image of ALCWE.PA

CHARWOOD ENERGY SA (ALCWE.PA) Stock Fundamental Analysis

EPA:ALCWE - Euronext Paris - Matif - FR001400AJ60 - Common Stock - Currency: EUR

2.9  -0.06 (-2.03%)

Fundamental Rating

3

ALCWE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ALCWE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALCWE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALCWE had negative earnings in the past year.
In the past year ALCWE has reported a negative cash flow from operations.
ALCWE had negative earnings in 4 of the past 5 years.
ALCWE had negative operating cash flow in 4 of the past 5 years.
ALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -31.76%
ROE -68.66%
ROIC N/A
ROA(3y)-15.48%
ROA(5y)-7.36%
ROE(3y)-30.7%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ALCWE.PA Yearly ROA, ROE, ROICALCWE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

In the last couple of years the Gross Margin of ALCWE has grown nicely.
ALCWE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 110.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.8%
GM growth 5YN/A
ALCWE.PA Yearly Profit, Operating, Gross MarginsALCWE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 100

4

2. Health

2.1 Basic Checks

ALCWE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCWE has more shares outstanding
ALCWE has a worse debt/assets ratio than last year.
ALCWE.PA Yearly Shares OutstandingALCWE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALCWE.PA Yearly Total Debt VS Total AssetsALCWE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that ALCWE is in the distress zone and has some risk of bankruptcy.
ALCWE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.64
ROIC/WACCN/A
WACC8.26%
ALCWE.PA Yearly LT Debt VS Equity VS FCFALCWE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALCWE has a Current Ratio of 1.62. This is a normal value and indicates that ALCWE is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.19 indicates that ALCWE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.19
ALCWE.PA Yearly Current Assets VS Current LiabilitesALCWE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

6

3. Growth

3.1 Past

ALCWE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.61%.
ALCWE shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.58%.
Measured over the past years, ALCWE shows a small growth in Revenue. The Revenue has been growing by 3.52% on average per year.
EPS 1Y (TTM)-123.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.9%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y3.52%
Revenue growth 5YN/A
Sales Q2Q%3.95%

3.2 Future

The Earnings Per Share is expected to grow by 74.80% on average over the next years. This is a very strong growth
ALCWE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.46% yearly.
EPS Next Y61.11%
EPS Next 2Y74.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year80%
Revenue Next 2Y47.71%
Revenue Next 3Y42.46%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCWE.PA Yearly Revenue VS EstimatesALCWE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
ALCWE.PA Yearly EPS VS EstimatesALCWE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2024 2025 2026 0 0.1 -0.1

1

4. Valuation

4.1 Price/Earnings Ratio

ALCWE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCWE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCWE.PA Price Earnings VS Forward Price EarningsALCWE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCWE.PA Per share dataALCWE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

ALCWE's earnings are expected to grow with 74.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALCWE!.
Industry RankSector Rank
Dividend Yield N/A

CHARWOOD ENERGY SA

EPA:ALCWE (8/8/2025, 7:00:00 PM)

2.9

-0.06 (-2.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.14M
Analysts86.67
Price Target5.61 (93.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.32%
Revenue NY rev (3m)5.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.99
P/FCF N/A
P/OCF N/A
P/B 2.97
P/tB 3.96
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.97
BVpS0.98
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.76%
ROE -68.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 110.94%
FCFM N/A
ROA(3y)-15.48%
ROA(5y)-7.36%
ROE(3y)-30.7%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.8%
GM growth 5YN/A
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.78%
Cap/Sales 10.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.19
Altman-Z 0.64
F-Score4
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)311.15%
Cap/Depr(5y)252.07%
Cap/Sales(3y)27.68%
Cap/Sales(5y)18.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.9%
EPS Next Y61.11%
EPS Next 2Y74.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.58%
Revenue growth 3Y3.52%
Revenue growth 5YN/A
Sales Q2Q%3.95%
Revenue Next Year80%
Revenue Next 2Y47.71%
Revenue Next 3Y42.46%
Revenue Next 5YN/A
EBIT growth 1Y-64.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y50.37%
EBIT Next 5YN/A
FCF growth 1Y52.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.82%
OCF growth 3YN/A
OCF growth 5YN/A